Nomura Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.5M Sell
61,942
-5,710
-8% -$333K 0.01% 657
2025
Q4
$4.02M Sell
67,652
-56,320
-45% -$3.07M 0.01% 639
2025
Q3
$6.71M Sell
123,972
-20,710
-14% -$1.18M 0.02% 527
2025
Q2
$7.95M Sell
144,682
-239,521
-62% -$14.1M 0.02% 499
2025
Q1
$27.2M Sell
384,203
-28,096
-7% -$1.89M 0.08% 241
2024
Q4
$27.1M Sell
412,299
-73,310
-15% -$4.91M 0.08% 239
2024
Q3
$34.1M Buy
485,609
+110,683
+30% +$9.25M 0.11% 203
2024
Q2
$30.9M Sell
374,926
-61,829
-14% -$5.15M 0.11% 203
2024
Q1
$38.1M Buy
436,755
+58,984
+16% +$5.28M 0.14% 174
2023
Q4
$36.4M Sell
377,771
-4,323
-1% -$382K 0.15% 159
2023
Q3
$33.8M Buy
382,094
+92,045
+32% +$8.19M 0.16% 153
2023
Q2
$25.1M Buy
290,049
+69,328
+31% +$6.52M 0.12% 207
2023
Q1
$21.5M Buy
220,721
+124,701
+130% +$12.9M 0.11% 213
2022
Q4
$9.94M Sell
96,020
-7,815
-8% -$734K 0.06% 313
2022
Q3
$8.8M Buy
103,835
+5,675
+6% +$505K 0.06% 327
2022
Q2
$8.13M Buy
98,160
+6,990
+8% +$557K 0.05% 343
2022
Q1
$7.03M Buy
91,170
+1,832
+2% +$153K 0.04% 405
2021
Q4
$7.89M Buy
89,338
+11,600
+15% +$957K 0.04% 378
2021
Q3
$6.01M Sell
77,738
-5,171
-6% -$408K 0.03% 423
2021
Q2
$6.92M Sell
82,909
-96,361
-54% -$7.64M 0.04% 396
2021
Q1
$13.5M Buy
179,270
+8,900
+5% +$727K 0.09% 250
2020
Q4
$14.9M Sell
170,370
-208,110
-55% -$16.5M 0.1% 211
2020
Q3
$28.8M Buy
378,480
+113,808
+43% +$11.5M 0.22% 99
2020
Q2
$32.6M Buy
264,672
+184,647
+231% +$18.4M 0.28% 81
2020
Q1
$6.76M Buy
80,025
+2,003
+3% +$173K 0.07% 246
2019
Q4
$6.6M Buy
78,022
+7
+0% +$529 0.06% 296
2019
Q3
$5.26M Buy
78,015
+2,517
+3% +$194K 0.05% 322
2019
Q2
$6.47M Sell
75,498
-200
-0.3% -$17.1K 0.06% 272
2019
Q1
$6.72M Sell
75,698
-7,141
-9% -$662K 0.07% 261
2018
Q4
$7.05M Sell
82,839
-795
-1% -$75.6K 0.08% 228
2018
Q3
$8.11M Sell
83,634
-34,384
-29% -$3.43M 0.08% 222
2018
Q2
$11.1M Buy
118,018
+4,478
+4% +$392K 0.12% 157
2018
Q1
$9.21M Buy
113,540
+5,733
+5% +$492K 0.1% 177
2017
Q4
$9.61M Buy
107,807
+4,927
+5% +$428K 0.11% 174
2017
Q3
$9.57M Buy
102,880
+7,337
+8% +$648K 0.12% 167
2017
Q2
$8.68M Buy
95,543
+384
+0.4% +$34.9K 0.12% 178
2017
Q1
$8.35M Buy
95,159
+3,390
+4% +$302K 0.12% 187
2016
Q4
$7.6M Buy
91,769
+17,666
+24% +$1.52M 0.14% 174
2016
Q3
$6.86M Buy
74,103
+16,012
+28% +$1.51M 0.12% 191
2016
Q2
$4.52M Buy
58,091
+23,406
+67% +$1.99M 0.08% 238
2016
Q1
$2.86M Buy
34,685
+15,996
+86% +$1.3M 0.05% 321
2015
Q4
$1.96M Sell
18,689
-10,984
-37% -$1.15M 0.04% 397
2015
Q3
$3.13M Buy
29,673
+3,023
+11% +$404K 0.06% 283
2015
Q2
$3.65M Buy
26,650
+1,400
+6% +$173K 0.07% 268
2015
Q1
$3.15M Buy
25,250
+1,230
+5% +$130K 0.06% 290
2014
Q4
$2.17M Sell
24,020
-330
-1% -$27.4K 0.04% 374
2014
Q3
$1.76M Buy
24,350
+2,000
+9% +$131K 0.03% 403
2014
Q2
$1.39M Hold
22,350
0.03% 475
2014
Q1
$1.52M Buy
22,350
+8,000
+56% +$590K 0.03% 437
2013
Q4
$1.01M Sell
14,350
-11,100
-44% -$754K 0.02% 549
2013
Q3
$1.84M Buy
25,450
+4,200
+20% +$279K 0.03% 398
2013
Q2
$1.19M Buy
+21,250
New +$1.32M 0.02% 528

Other funds holding BMRN